PURPOSE: To explore the retinoschisin (RS1) protein biochemical phenotype from an RS1 exon-5 deletion/insertion frame-shift mutation in a family with X-linked retinoschisis (XLRS) and describe the clinical and electrophysiological features. METHODS: Six XLRS males underwent ophthalmic examination and electroretinogram (ERG) recording. The RS1 gene was sequenced. Mutant RS1-RNA and protein expression were assessed by transfecting COS-7 cells with minigene constructs. RESULTS: All six males carried the RS1 c354del1-ins18 mutation in which an 18-bp insertion replaced nucleotide 354, duplicating the adjacent upstream intron 4-to-exon 5 junction and creating a premature termination codon downstream. Analysis indicated normal pre-mRNA splicing producing mRNA transcripts. Truncated RS1 protein was expressed transiently but was degraded rapidly by a proteasomal pathway rather than by nonsense-mediated mRNA decay. Two boys, 1.5 and 5 years of age, had foveal cysts and minimal peripheral schisis, and retained near-normal scotopic b-wave amplitude and normal ERG waveforms. The 5-year-old's ERG was diminished when repeated 3 years later. Four older XLRS relatives 32 to 45 years old had substantial b-wave loss and strongly electronegative ERGs; three had overt macular atrophy. Cross-sectional family analysis showed the b-/a-wave amplitude ratio as inversely related to age in the six males. CONCLUSIONS: The c354del1-ins18 mutation caused an RS1-null biochemical phenotype and a progressive clinical phenotype in a 5-year-old boy, whereas the older XLRS relatives had macular atrophy and marked ERG changes. The phenotypic heterogeneity with age by cross-sectional study of this family mutation argues that XLRS disease is not stationary and raises questions regarding factors involved in progression.
PURPOSE: To explore the retinoschisin (RS1) protein biochemical phenotype from an RS1 exon-5 deletion/insertion frame-shift mutation in a family with X-linked retinoschisis (XLRS) and describe the clinical and electrophysiological features. METHODS: Six XLRS males underwent ophthalmic examination and electroretinogram (ERG) recording. The RS1 gene was sequenced. Mutant RS1-RNA and protein expression were assessed by transfecting COS-7 cells with minigene constructs. RESULTS: All six males carried the RS1c354del1-ins18 mutation in which an 18-bp insertion replaced nucleotide 354, duplicating the adjacent upstream intron 4-to-exon 5 junction and creating a premature termination codon downstream. Analysis indicated normal pre-mRNA splicing producing mRNA transcripts. Truncated RS1 protein was expressed transiently but was degraded rapidly by a proteasomal pathway rather than by nonsense-mediated mRNA decay. Two boys, 1.5 and 5 years of age, had foveal cysts and minimal peripheral schisis, and retained near-normal scotopic b-wave amplitude and normal ERG waveforms. The 5-year-old's ERG was diminished when repeated 3 years later. Four older XLRS relatives 32 to 45 years old had substantial b-wave loss and strongly electronegative ERGs; three had overt macular atrophy. Cross-sectional family analysis showed the b-/a-wave amplitude ratio as inversely related to age in the six males. CONCLUSIONS: The c354del1-ins18 mutation caused an RS1-null biochemical phenotype and a progressive clinical phenotype in a 5-year-old boy, whereas the older XLRS relatives had macular atrophy and marked ERG changes. The phenotypic heterogeneity with age by cross-sectional study of this family mutation argues that XLRS disease is not stationary and raises questions regarding factors involved in progression.
Authors: Jonathan L Prenner; Antonio Capone; Stefano Ciaccia; Yuichiro Takada; Paul A Sieving; Michael T Trese Journal: Retina Date: 2006-09 Impact factor: 4.256
Authors: David Y Kim; Kimberly A Neely; Joseph W Sassani; Tamara R Vrabec; Avinash Tantri; Arcilee Frost; Larry A Donoso Journal: Retina Date: 2006-10 Impact factor: 4.256
Authors: Yuichiro Takada; Camasamudram Vijayasarathy; Yong Zeng; Sten Kjellstrom; Ronald A Bush; Paul A Sieving Journal: Invest Ophthalmol Vis Sci Date: 2008-08 Impact factor: 4.799
Authors: Xinyu Zhang; Edward J Dudek; Bingfen Liu; Linlin Ding; Alexandre F Fernandes; Jack J Liang; Joseph Horwitz; Allen Taylor; Fu Shang Journal: Invest Ophthalmol Vis Sci Date: 2007-09 Impact factor: 4.799
Authors: Sten Kjellstrom; Ronald A Bush; Yong Zeng; Yuichiro Takada; Paul A Sieving Journal: Invest Ophthalmol Vis Sci Date: 2007-08 Impact factor: 4.799
Authors: N Z Gregori; A M Berrocal; G Gregori; T G Murray; R W Knighton; H W Flynn; S Dubovy; C A Puliafito; P J Rosenfeld Journal: Br J Ophthalmol Date: 2008-11-19 Impact factor: 4.638
Authors: Balázs Lesch; Viktória Szabó; Melinda Kánya; Balázs Varsányi; Gábor M Somfai; János Hargitai; Rita Vámos; Orsolya Fiedler; Agnes Farkas Journal: Mol Vis Date: 2008-08-25 Impact factor: 2.367
Authors: B Lesch; V Szabó; M Kánya; G M Somfai; R Vámos; B Varsányi; Zs Pámer; K Knézy; Gy Salacz; M Janáky; M Ferencz; J Hargitai; A Papp; A Farkas Journal: Mol Vis Date: 2008-12-12 Impact factor: 2.367
Authors: Catherine Cukras; Henry E Wiley; Brett G Jeffrey; H Nida Sen; Amy Turriff; Yong Zeng; Camasamudram Vijayasarathy; Dario Marangoni; Lucia Ziccardi; Sten Kjellstrom; Tae Kwon Park; Suja Hiriyanna; J Fraser Wright; Peter Colosi; Zhijian Wu; Ronald A Bush; Lisa L Wei; Paul A Sieving Journal: Mol Ther Date: 2018-07-07 Impact factor: 11.454
Authors: Kristen Bowles; Catherine Cukras; Amy Turriff; Yuri Sergeev; Susan Vitale; Ronald A Bush; Paul A Sieving Journal: Invest Ophthalmol Vis Sci Date: 2011-11-29 Impact factor: 4.799
Authors: Camasamudram Vijayasarathy; Ruifang Sui; Yong Zeng; Guoxing Yang; Fei Xu; Rafael C Caruso; Richard A Lewis; Lucia Ziccardi; Paul A Sieving Journal: Hum Mutat Date: 2010-11 Impact factor: 4.878
Authors: Brett G Jeffrey; Catherine A Cukras; Susan Vitale; Amy Turriff; Kristin Bowles; Paul A Sieving Journal: Transl Vis Sci Technol Date: 2014-10-03 Impact factor: 3.283